Free Trial

Vanda Pharmaceuticals (VNDA) SEC Filings & 10K Form

Vanda Pharmaceuticals logo
$4.60 -0.17 (-3.56%)
Closing price 03/27/2025 04:00 PM Eastern
Extended Trading
$4.60 0.00 (-0.11%)
As of 03/27/2025 06:43 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Vanda Pharmaceuticals SEC Filings

DateFilerForm TypeView
03/17/2025
8:15 AM
Vanda Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/06/2025
4:53 PM
Polymeropoulos Mihael Hristos (Reporting)
Vanda Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
3:45 PM
Polymeropoulos Mihael Hristos (Reporting)
Vanda Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
3:46 PM
Birznieks Gunther (Reporting)
Vanda Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
3:46 PM
Vanda Pharmaceuticals (Issuer)
Wijkstrom Joakim (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
3:44 PM
Vanda Pharmaceuticals (Issuer)
Williams Timothy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
3:45 PM
Moran Kevin Patrick (Reporting)
Vanda Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2025
4:30 PM
Polymeropoulos Mihael Hristos (Reporting)
Vanda Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2025
3:13 PM
Polymeropoulos Mihael Hristos (Reporting)
Vanda Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/25/2025
6:38 PM
Polymeropoulos Mihael Hristos (Reporting)
Vanda Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/24/2025
6:04 PM
Moran Kevin Patrick (Reporting)
Vanda Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/20/2025
7:21 PM
Vanda Pharmaceuticals (Issuer)
Wijkstrom Joakim (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/20/2025
6:43 PM
Vanda Pharmaceuticals (Issuer)
Williams Timothy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/20/2025
6:44 PM
Birznieks Gunther (Reporting)
Vanda Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/20/2025
6:44 PM
Moran Kevin Patrick (Reporting)
Vanda Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/20/2025
6:45 PM
Polymeropoulos Mihael Hristos (Reporting)
Vanda Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/20/2025
3:46 PM
Vanda Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/07/2025
12:40 PM
BlackRock, Inc. (Filed by)
Vanda Pharmaceuticals (Subject)
Form SCHEDULE 13G/A
02/05/2025
12:23 PM
BlackRock, Inc. (Filed by)
Vanda Pharmaceuticals (Subject)
Form SCHEDULE 13G/A
01/27/2025
7:22 AM
Vanda Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/18/2024
4:45 PM
Mitchell Stephen Ray (Reporting)
Vanda Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/07/2024
6:07 AM
Vanda Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/15/2024
7:00 AM
Vanda Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/03/2024
4:00 PM
Vanda Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/19/2024
7:10 AM
Vanda Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/08/2024
6:47 AM
Vanda Pharmaceuticals (Filer)
Form 8-A12B/A
08/08/2024
6:29 AM
Vanda Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/01/2024
6:01 AM
Vanda Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/31/2024
3:05 PM
Vanda Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/29/2024
4:21 PM
Moran Kevin Patrick (Reporting)
Vanda Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/29/2024
4:24 PM
Moran Kevin Patrick (Reporting)
Vanda Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2024
3:38 PM
Vanda Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/06/2024
3:30 PM
Vanda Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/24/2024
3:43 PM
Chrousos Phaedra (Reporting)
Vanda Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/24/2024
3:49 PM
Vanda Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/21/2024
3:52 PM
Vanda Pharmaceuticals (Issuer)
Ward Anne Sempowski (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/21/2024
3:53 PM
Mitchell Stephen Ray (Reporting)
Vanda Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/21/2024
3:53 PM
DUGAN RICHARD W (Reporting)
Vanda Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/21/2024
3:55 PM
Honore Tage (Reporting)
Vanda Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/21/2024
3:34 PM
Vanda Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
05/20/2024
4:26 PM
Vanda Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
Caught on Camera: Elon Musk’s “Area 51” (Ad)

You won’t believe what tech legend Jeff Brown found in what he calls Elon Musk’s “Area 51.” (Click here to see this footage.) A lot of people believe the U.S. government is hiding aliens at the highly classified U.S. Air Force facility in Nevada known as “Area 51.”

Click here now because after May 1st, it could be too late.
05/09/2024
4:15 PM
Vanda Pharmaceuticals (Filer)
Form DEFA14A
05/09/2024
6:07 AM
Vanda Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/07/2024
3:51 PM
Vanda Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/29/2024
5:17 AM
Vanda Pharmaceuticals (Filer)
Form DEF 14A
04/29/2024
5:26 AM
Vanda Pharmaceuticals (Filer)
Form ARS
04/17/2024
4:26 PM
Vanda Pharmaceuticals (Filer)
Form 8-A12B
04/17/2024
4:19 PM
Vanda Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/03/2024
3:32 PM
Vanda Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)

Remove Ads

Related Companies and Tools


This page (NASDAQ:VNDA) was last updated on 3/28/2025 by MarketBeat.com Staff
From Our Partners